Clinical Trial Update: Treating Refractory Schizophrenia With rTMS [NA]

View source ↗

Summary

A clinical trial investigating repetitive transcranial magnetic stimulation (rTMS) for refractory schizophrenia was terminated; results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Seton Healthcare Family | Conditions: Schizophrenia | NA | Status: TERMINATED | Results posted: 2021-04-12